Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 39,000 people in 75 countries and markets its products in more than 180 countries.
80 Al. Panagouli str. & 65 Agias Triados str., 153 43 Agia Paraskevi Athens Greece
+30 (210) 6071 600
+30 (210) 6395 101
Head of Market Access, Public Affairs & Media Communication: Mary Karageorgou